Experiences with
Oncovin3 public posts
Transformation of Richter's Transformation Treatment to combination targeted therapy - tislelizumab +zanubrutinib (ASH 2023)
www.nature.com/articles/s41591-023-02722-9[/i]
[i]
[/i]
*R-CHOP is a combination of;
R = Rituximab, an anti-CD20 monoclonal antibody, the 'R' in FCR, BR, VR, etc
C = Cyclophosphamide, an alkylating agent, the 'C' in FCR
H = Doxorubicin Hydrochloride (Hydroxydaunomycin), an anthracycline
O = Vincristine Sulfate (Oncovin
Want to take advantage of all our features? Just log in!
or